Timing of Postoperative Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Squamous Cell Carcinoma

Melanie Townsend, Todd DeWees, Jennifer Gross, Mackenzie Daly, Hiram Gay, Wade Thorstad, Ryan S. Jackson

Research output: Contribution to journalArticle

Abstract

Objective: Optimal timing of postoperative radiotherapy (PORT) remains understudied in human papillomavirus (HPV)–related oropharyngeal squamous cell carcinoma. Objectives are to determine if delays between surgery and radiotherapy, breaks during radiotherapy, disease, or patient factors are associated with recurrence or survival decrements in HPV-related disease. Design: Retrospective review. Setting: Academic medical center. Subjects: A total of 240 cases of HPV-positive oropharyngeal squamous cell carcinoma from 2000 to 2016. Methods: Patient and tumor characteristics (American Joint Committee on Cancer, eighth edition), delays to radiation initiation, and breaks during radiation were recorded. Overall survival (OS) and recurrence-free survival (RFS) were analyzed. Results: RFS and OS were not significantly affected by delays to PORT >6 weeks or by treatment intervals >100 days (surgery to PORT completion). Breaks during PORT significantly imparted an OS detriment (hazard ratio [HR], 2.4; 95% CI, 1.2-4.8). Advanced-stage disease was significantly associated with reduced RFS and OS. Subgroup analysis of stage I versus stage II/III disease found that >6 weeks to PORT initiation and treatment intervals >100 days did not significantly decrease RFS or OS in either stage group. Advanced-stage disease was significantly associated with worsened OS (HR, 6.6; 95% CI, 2.3-19.1) and RFS (HR, 5.3; 95% CI, 1.5-18.4). Breaks during PORT significantly reduced RFS (HR, 3.6; 95% CI, 1.2-10.8) and OS (HR, 3.2; 95% CI, 1.2-9.0) in the stage II/III subset. Conclusion: Delays to radiotherapy initiation and prolonged treatment time did not affect recurrence or survival in HPV-related oropharyngeal disease. Locoregionally advanced disease was consistently associated with worse outcomes. Breaks during PORT may affect recurrence and survival, although larger studies are needed to confirm this finding.

Original languageEnglish (US)
JournalOtolaryngology - Head and Neck Surgery (United States)
DOIs
StatePublished - Jan 1 2019

Fingerprint

Squamous Cell Carcinoma
Radiotherapy
Survival
Recurrence
Radiation
Ambulatory Surgical Procedures
Neoplasms
Therapeutics

Keywords

  • HPV positive squamous cell carcinoma
  • oropharynx
  • postoperative radiotherapy

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Cite this

Timing of Postoperative Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Squamous Cell Carcinoma. / Townsend, Melanie; DeWees, Todd; Gross, Jennifer; Daly, Mackenzie; Gay, Hiram; Thorstad, Wade; Jackson, Ryan S.

In: Otolaryngology - Head and Neck Surgery (United States), 01.01.2019.

Research output: Contribution to journalArticle

@article{87377d98f52b40a0ad9e4e9feec2a03e,
title = "Timing of Postoperative Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Squamous Cell Carcinoma",
abstract = "Objective: Optimal timing of postoperative radiotherapy (PORT) remains understudied in human papillomavirus (HPV)–related oropharyngeal squamous cell carcinoma. Objectives are to determine if delays between surgery and radiotherapy, breaks during radiotherapy, disease, or patient factors are associated with recurrence or survival decrements in HPV-related disease. Design: Retrospective review. Setting: Academic medical center. Subjects: A total of 240 cases of HPV-positive oropharyngeal squamous cell carcinoma from 2000 to 2016. Methods: Patient and tumor characteristics (American Joint Committee on Cancer, eighth edition), delays to radiation initiation, and breaks during radiation were recorded. Overall survival (OS) and recurrence-free survival (RFS) were analyzed. Results: RFS and OS were not significantly affected by delays to PORT >6 weeks or by treatment intervals >100 days (surgery to PORT completion). Breaks during PORT significantly imparted an OS detriment (hazard ratio [HR], 2.4; 95{\%} CI, 1.2-4.8). Advanced-stage disease was significantly associated with reduced RFS and OS. Subgroup analysis of stage I versus stage II/III disease found that >6 weeks to PORT initiation and treatment intervals >100 days did not significantly decrease RFS or OS in either stage group. Advanced-stage disease was significantly associated with worsened OS (HR, 6.6; 95{\%} CI, 2.3-19.1) and RFS (HR, 5.3; 95{\%} CI, 1.5-18.4). Breaks during PORT significantly reduced RFS (HR, 3.6; 95{\%} CI, 1.2-10.8) and OS (HR, 3.2; 95{\%} CI, 1.2-9.0) in the stage II/III subset. Conclusion: Delays to radiotherapy initiation and prolonged treatment time did not affect recurrence or survival in HPV-related oropharyngeal disease. Locoregionally advanced disease was consistently associated with worse outcomes. Breaks during PORT may affect recurrence and survival, although larger studies are needed to confirm this finding.",
keywords = "HPV positive squamous cell carcinoma, oropharynx, postoperative radiotherapy",
author = "Melanie Townsend and Todd DeWees and Jennifer Gross and Mackenzie Daly and Hiram Gay and Wade Thorstad and Jackson, {Ryan S.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/0194599819847144",
language = "English (US)",
journal = "Otolaryngology - Head and Neck Surgery (United States)",
issn = "0194-5998",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Timing of Postoperative Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Squamous Cell Carcinoma

AU - Townsend, Melanie

AU - DeWees, Todd

AU - Gross, Jennifer

AU - Daly, Mackenzie

AU - Gay, Hiram

AU - Thorstad, Wade

AU - Jackson, Ryan S.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Optimal timing of postoperative radiotherapy (PORT) remains understudied in human papillomavirus (HPV)–related oropharyngeal squamous cell carcinoma. Objectives are to determine if delays between surgery and radiotherapy, breaks during radiotherapy, disease, or patient factors are associated with recurrence or survival decrements in HPV-related disease. Design: Retrospective review. Setting: Academic medical center. Subjects: A total of 240 cases of HPV-positive oropharyngeal squamous cell carcinoma from 2000 to 2016. Methods: Patient and tumor characteristics (American Joint Committee on Cancer, eighth edition), delays to radiation initiation, and breaks during radiation were recorded. Overall survival (OS) and recurrence-free survival (RFS) were analyzed. Results: RFS and OS were not significantly affected by delays to PORT >6 weeks or by treatment intervals >100 days (surgery to PORT completion). Breaks during PORT significantly imparted an OS detriment (hazard ratio [HR], 2.4; 95% CI, 1.2-4.8). Advanced-stage disease was significantly associated with reduced RFS and OS. Subgroup analysis of stage I versus stage II/III disease found that >6 weeks to PORT initiation and treatment intervals >100 days did not significantly decrease RFS or OS in either stage group. Advanced-stage disease was significantly associated with worsened OS (HR, 6.6; 95% CI, 2.3-19.1) and RFS (HR, 5.3; 95% CI, 1.5-18.4). Breaks during PORT significantly reduced RFS (HR, 3.6; 95% CI, 1.2-10.8) and OS (HR, 3.2; 95% CI, 1.2-9.0) in the stage II/III subset. Conclusion: Delays to radiotherapy initiation and prolonged treatment time did not affect recurrence or survival in HPV-related oropharyngeal disease. Locoregionally advanced disease was consistently associated with worse outcomes. Breaks during PORT may affect recurrence and survival, although larger studies are needed to confirm this finding.

AB - Objective: Optimal timing of postoperative radiotherapy (PORT) remains understudied in human papillomavirus (HPV)–related oropharyngeal squamous cell carcinoma. Objectives are to determine if delays between surgery and radiotherapy, breaks during radiotherapy, disease, or patient factors are associated with recurrence or survival decrements in HPV-related disease. Design: Retrospective review. Setting: Academic medical center. Subjects: A total of 240 cases of HPV-positive oropharyngeal squamous cell carcinoma from 2000 to 2016. Methods: Patient and tumor characteristics (American Joint Committee on Cancer, eighth edition), delays to radiation initiation, and breaks during radiation were recorded. Overall survival (OS) and recurrence-free survival (RFS) were analyzed. Results: RFS and OS were not significantly affected by delays to PORT >6 weeks or by treatment intervals >100 days (surgery to PORT completion). Breaks during PORT significantly imparted an OS detriment (hazard ratio [HR], 2.4; 95% CI, 1.2-4.8). Advanced-stage disease was significantly associated with reduced RFS and OS. Subgroup analysis of stage I versus stage II/III disease found that >6 weeks to PORT initiation and treatment intervals >100 days did not significantly decrease RFS or OS in either stage group. Advanced-stage disease was significantly associated with worsened OS (HR, 6.6; 95% CI, 2.3-19.1) and RFS (HR, 5.3; 95% CI, 1.5-18.4). Breaks during PORT significantly reduced RFS (HR, 3.6; 95% CI, 1.2-10.8) and OS (HR, 3.2; 95% CI, 1.2-9.0) in the stage II/III subset. Conclusion: Delays to radiotherapy initiation and prolonged treatment time did not affect recurrence or survival in HPV-related oropharyngeal disease. Locoregionally advanced disease was consistently associated with worse outcomes. Breaks during PORT may affect recurrence and survival, although larger studies are needed to confirm this finding.

KW - HPV positive squamous cell carcinoma

KW - oropharynx

KW - postoperative radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85067802732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067802732&partnerID=8YFLogxK

U2 - 10.1177/0194599819847144

DO - 10.1177/0194599819847144

M3 - Article

JO - Otolaryngology - Head and Neck Surgery (United States)

JF - Otolaryngology - Head and Neck Surgery (United States)

SN - 0194-5998

ER -